Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. audio, 8-K earnings release, 10-Q stay in one workspace.
HBIO
$8.34
+2.58%
HBIO
· Harvard Bioscience Inc
Market Cap
$36.24M
Shares
4.55M
Volume · Oct 2
15.47K
Avg daily vol (3M)
17.96K
All webcasts
Earnings call · FY2026 Q2
Harvard Bioscience Inc (HBIO) Q2 2026 Earnings Call
Forward guidance
6 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$22.73M
+11.1% YoY
Diluted EPS
-$0.64
Gross margin
55.6%
-0.8 pp YoY
Net income
-$2.91M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 11, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
Initiated
third quarter of 2026
|
$21M – $22.6M | — | |
|
Adjusted gross margin
Initiated
third quarter of 2026
|
56% – 58% | Non-GAAP | |
|
Adjusted EBITDA
Initiated
third quarter of 2026
|
$1.5M – $2.5M | Non-GAAP | |
|
Revenue growth
Initiated
full-year 2026
|
3% – 5% | — | |
|
Adjusted gross margin
Initiated
full-year 2026
|
57% – 59% | Non-GAAP | |
|
Adjusted EBITDA growth
Initiated
full-year 2026
|
6% – 10% | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
Listen to the call
Audio replay
Play the complete captured earnings call.
21:28
Audio
Audio replay
A speaker-labelled transcript is not available for this event yet.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 11, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 11, 2026 · complete as-filed document